Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch

NCT06493526 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids.

Sponsor

University Hospital, Antwerp